STÉRIMAR® Soothing Cream to alleviate irritation in the nasal contour region
During colds or rhinitis, STÉRIMAR® Soothing Cream brings rapid, lasting relief to the irritated epidermis,
boosts the skin barrier function and visibly reduces redness.
The skin is protected and moisturised, and suppleness is restored.
STÉRIMAR® Soothing Cream is the solution to the risk of irritated skin:
The skin is the first barrier against external aggression. When it is altered, the skin becomes more sensitive and is especially permeable to the cold and bacteria. It loses its immune defences and the skin tissues suffer and dry out.
This can be remedied by boosting the skin's natural repair process with the help of a soothing cream and also by preventing the recurrence of irritation by strengthening the natural skin's protection process.
Its exclusive formula with Blue Algae and Aloe Vera is effective in all of the nasal contour region - areas particularly affected during the winter months (cold, dry air, constant blowing of the nose, etc.)
Paraben-free, this cream is specially formulated for the irritated nasal contour region with clinically proven efficacy (dermatologically tested in 42 patients*)
STÉRIMAR® Soothing Cream – the assets for those* who have already tried it:
- Calms irritation: 93%
- Reduces redness: 88%
- Easy to apply: 100%
- Leaves no greasy traces on the skin: 88%
- Penetrates rapidly: 93%
- Pleasant texture: 88%
STÉRIMAR® Soothing Cream, 15-ml tube with cannula, slips into your bag with the first cold snap of winter!
ACL Code: 995 875 6
EAN Code: 333 130 009 753 5
It's the essential complement for STÉRIMAR® sprays and particularly for a blocked Nose.
Instructions for use :
Apply a nut-sized quantity of cream in a fine layer to the irritated area.
Gently massage into the skin several times a day.
Repeat as required.
In the event of marked irritation or during the night for greater protection, apply a thick layer.
For external use. Avoid any contact with the eyes. Keep out of the reach of children.
*Dermscan 2011 efficacy / safety clinical study – 42 patients